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Abstract
We previously demonstrated that the androgenic and anti-androgenic effects of endocrine
disruptors (EDs) alter reproductive function and exert distinct effects on developing male
reproductive organs. To further investigate these effects, we used an immature rat model to
examine the effects of di-(2 ethylhexyl) phthalate (DEHP) and flutamide (Flu) on the male
reproductive system. Immature male SD rats were treated daily with DEHP and Flu on postnatal
days (PNDs) 21 to 35, in a dose-dependent manner. As results, the weights of the testes, prostate,
and seminal vesicle and anogenital distances (AGD) decreased significantly in response to high
doses of DEHP or Flu. Testosterone (T) levels significantly decreased in all DEHP- treated groups,
whereas luteinizing hormone (LH) plasma levels were not altered by any of the two treatments at
PND 36. However, treatment with DEHP or Flu induced histopathological changes in the testes,
wherein degeneration and disorders of Leydig cells, germ cells and dilatation of tubular lumen were
observed in a dose-dependent manner. Conversely, hyperplasia and denseness of Leydig, Sertoli
and germ cells were observed in rats given with high doses of Flu. The results by cDNA microarray
analysis indicated that 1,272 genes were up-regulated by more than two-fold, and 1,969 genes were
down-regulated in response to DEHP, Flu or both EDs. These genes were selected based on their
markedly increased or decreased expression levels. These genes have been also classified on the
basis of gene ontology (e.g., steroid hormone biosynthetic process, regulation of transcription,
signal transduction, metabolic process, biosynthetic process...). Significant decreases in gene
expression were observed in steroidogenic genes (i.e., Star, Cyp11a1 and Hsd3b). In addition, the
expression of a common set of target genes, including CaBP1, Vav2, Plcd1, Lhx1 and Isoc1, was
altered following exposure to EDs, suggesting that they may be marker genes to screen for the anti-
androgenic or androgenic effects of EDs. Overall, our results demonstrated that exposure to
DEHP, Flu or both EDs resulted in a alteration of gene expression in the testes of immature male
rats. Furthermore, the toxicological effects of these EDs on the male reproductive system resulted
from their anti-androgenic effects. Taken together, these results provide a new insight into the
molecular mechanisms underlying the detrimental impacts of EDs, in regards to anti-androgenic
effects in humans and wildlife.
Published: 26 September 2009
Reproductive Biology and Endocrinology 2009, 7:104 doi:10.1186/1477-7827-7-104
Received: 3 October 2008
Accepted: 26 September 2009
This article is available from: http://www.rbej.com/content/7/1/104
© 2009 Vo et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
Page 2 of 15
(page number not for citation purposes)
Background
Over the past two decades, the detrimental effects of
endocrine disruptors (EDs) on wildlife and humans have
become a major public health concern. Endocrine disrup-
tors, a large group of environmental pollutants, are
believed to act as agonists or antagonists of androgens and
estrogens, which are key hormones involved in many
physiological processes. These pollutants have been
linked to male reproductive defects in humans, including
an increase in the incidence of testicular cancer [1], and
declining semen quality [2]. Evidence of cryptorchidism,
undescended testis and hypospadias have also been dem-
onstrated [3]. In addition, EDs have been linked to devel-
opmental problems in the testis and reproductive tract,
including reductions in fertility and litter size, induction
of cryptorchidism and testicular atrophy [4,5].
Normal development of the male reproductive tract
requires interactions between many biological factors and
hormones. In particular, androgen hormones are essential
to this process. However, many environmental chemicals
have androgenic or anti-androgenic effects, or can mimic
androgenic activities (i.e., thereby stimulating an andro-
gen-dependent response). Adverse trends in human and
animal male reproductive health, particularly with regards
to the regulation of environmental factors, suggest that
future generations will be at greater risk. Previous reports
have suggested that male reproductive system disorders,
which often originate during the fetal stage, can appear as
testicular dysgenesis syndrome (TDS) after birth [6].
Previous studies demonstrated the possible effects of
antiandrogenic- EDs [i.e., flutamide and/or di- (2 ethyl-
hexyl) phthalate] on the reduction of androgen synthesis
during the development of the male reproductive tract
[7,8]. These EDs appear to induce abnormalities in the
formation of external genitalia, i.e., hypospadias, cryp-
torchidism and agenesis of the epididymis, vas deferens
and prostate. In additional, the effects of these EDs were
also observed with regards to AGD and nipple retention
[5]. In humans, some of these alterations are permanent
and affect testes function later in life [9]. Although ED-
induced harmful effects on male reproduction have been
demonstrated, the molecular mechanisms by which EDs
disrupt testis development and affect testicular dysgenesis
are not clearly understood.
Di-ethylhexyl phthalate (DEHP) is widely used as a plas-
ticizer in commercial products [10]. The effects of DEHP
on male reproductive development have been well stud-
ied in rats [11]. In addition, phthalates and their metabo-
lites can be released from such products and have been
detected in the environment [12], posing potential health
risks for humans and wildlife. Infants may be exposed to
phthalates in the womb [13], via breastfeeding [14] or
from medical devices in neonatal intensive care units [15].
Although DEHP has been reported to modulate fetal tes-
tosterone production [16], testicular physiology, and
mammalian reproduction and fertility [17], the exact
mechanisms by which DEHP exerts detrimental effects on
body have not yet been fully elucidated. Previous studies
have demonstrated the adverse effects of DEHP on the
hypothalamic-pituitary-gonadal axis in neonatal female
rats, as well as on ex vivo steroidogenesis in granulosa
cells (GCs) and secretion of LH by gonadotropes [18].
Moreover, exposure to phthalates during reproductive
tract development reduces the number of Sertoli cells (i.e.,
the major somatic cell type, which supports spermatogen-
esis) [19]. In addition, DEHP and its metabolites decrease
testicular testosterone levels in rodents [20], suggesting
potential impacts of these contaminants on Leydig cells. A
recent study has indicated that a variety of steroidogenesis
related genes were altered following phthalate- exposure
and a down-regulation of most of genes involved in testo-
sterone (T) biosynthetic pathways was observed, indicat-
ing the potential mechanism for decreased T synthesis
induced by phthalate exposure [21]. Other study has
reported a similar genetic response in the fetal and prepu-
bertal testes of rats exposed to these environmental chem-
icals [22].
Flutamide (Flu) is a well-known AR antagonist that is
widely used in therapies for androgen-dependent prostate
cancer [23] Pre- and postnatal exposure of rats to Flu alters
androgen-dependent reproductive development and
function [24]. Flu exposure also increases plasma LH lev-
els and stimulates intracellular steroidogenesis in rat tes-
tes. In addition, lower ventral prostate and seminal vesicle
weights have also been reported, suggesting that Flu exerts
anti-androgenic effects on androgen-targeting organs
[25]. It has been indicated that exposure of rats to Flu
caused a dysregulation in expression of hypothalamus/
pituitary hormone genes and consequently this may affect
gonadotropin release and induce an over-expression of
testicular steroidogenic enzyme genes [26].
In this study, we used an immature rat model of develop-
ment to examine the adverse effects of DEHP and Flu on
the male reproductive system. In particular, we examined
the effects of DEHP and Flu on the male reproductive tract
and the production of testosterone and LH. We also
assessed the histopathological changes of the testis in
response to ED exposure. AGD values were used as andro-
gen-dependent markers to assess the anti-androgenic and
androgenic activities of the EDs. In addition, we examined
alterations in gene expression in the testis of immature
rats following DEHP or Flu treatment. Testosterone propi-
onate (TP), an androgen agonist, was used as an indica-
tion of androgenic activity in androgen-responsive
organs. Our findings will contribute to a better under-Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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standing of the detrimental effects of anti-androgenic EDs
on humans and wildlife.
Methods
Chemicals
Testosterone propionate (TP; # 203-08433) and di-(2-eth-
lhexyl) phthalate (DEHP; # 80032) were purchased from
the Wako Chemical Company (Osaka, Japan). Flutamide
(Flu; # F-9397) and corn oil (i.e., used as a vehicle) were
obtained from Sigma-Aldrich Ltd. (St Louis, MO, USA).
Animals and treatment
Sprague-Dawley (SD; 32 males) immature rats were pur-
chased from SamTaKo-Bio Korea (Chungbuk, Korea). The
rats were housed in polycarbonate cages in a controlled
environment, with an illumination schedule of 12 hour
light/12 hour dark. Rats were fed a diet of soy-free pellets
(Samyang Ltd., Korea), and water was provided ad libitum.
All experimental procedures, including those involving
animals, were approved by the ethics committee of
Chungbuk National University. From postnatal days
(PNDs) 21 to 35, rats were treated daily with TP (1 mg/kg
body weight [BW]/day), DEHP (10, 100 or 500 mg/kg
BW/day), Flu (1, 10 or 50 mg/kg BW/day) via oral gavage
or with corn oil (5 ml/kg BW/day) as a vehicle. Dosages
were adjusted according to changes in body weight. Body
weights, clinical signs and abnormal behaviors were
recorded daily throughout the experimental periods. All
animals were euthanized by exposure to ethyl ether 24
hours after the final treatment. Blood was collected from
the descending vena cava and serum was prepared for hor-
monal analysis. Changes in the weights of testes, epidi-
dymides, prostate and seminal vesicles were recorded.
Four testes were collected from each group for total RNA
isolation. Other testes were fixed in Bouin's solution, par-
affin embedded, and sectioned at 5 μm for histopatholog-
ical examination.
Hormonal measurements
After collecting blood from the abdominal aorta, serum
was prepared and stored at -20°C for testosterone and LH
analyses. The Testosterone Enzyme Immunoassay kit (No.
900-065) was obtained from Assay Designs, Inc (Ann
Arbor, USA) and the LH Detect Kit was purchased from
INRA (Nouzilly, France). ELISA tests were performed
according to the manufacturer's recommendations. The
coefficients of variation (CV) of intra- and inter-assays
were 4% and 14%.
Total RNA preparation
Total RNA was extracted from the testes of immature male
rats using Trizol (Invitrogen, Carlsbad, CA, USA), accord-
ing to the manufacturer's recommendations. To make
cDNAs from mRNAs for microarray analysis, the same
quantity of each RNA sample from the treated groups or
control group was pooled. The concentration and quality
of each RNA sample was determined by measuring
absorbances at 260 nm and 280 nm.
cDNA microarray analysis of testes
The oligo chip of GeneChip® Rat Genome 230 2.0 Array
(Affymetrix, CA, USA), containing over 31,000 probe sets
and representing over 28,000 well-substantiated rat genes,
were used according to the supplier's instructions. Briefly,
total RNA (i.e., 30 μg) from each testis was converted to
cDNA for use for microarray analyses. The cDNA products
were subsequently subjected to in vitro transcription using
biotinylated cytidine 5'-triphosphate and uridine-5'-tri-
phosphate. Fluorescent labels were incorporated during
reverse-transcription of pooled poly (A)+ RNA from the
testes of animals in the DEHP, Flu or control groups, after
priming with oligo (dT) primers (Ambion, Austin, TX).
Four replicates per group were used for hybridization,
thus all together 12 microarrays (3 groups × 4 biological
replicates) were employed to evaluate gene alteration by
EDs in this study. The fluorescent targets (i.e., Cy3-dCTP
controls and Cy5-dCTP experimental cDNAs) were
mixed, added to the microarray surface and covered with
a cover slip. After overnight incubation at 65°C in a
humidified environment, microchips were washed and
scanned using a GeneChip Scanner 3000 (Affymatrix, Inc,
CA, USA). Quantitative values for signals were calculated
using GenePix Pro software, version 5.1 (Molecular
Devices Co., CA, USA). Data analysis was performed using
the GenePlex (Istech, Inc., Korea). Logged gene expression
ratios were normalized by LOWESS (Locally weighted
scatter plot smoother) regression as previously described
[27]. The biological pathways of the genes were classified
based on pathway analysis in which the classification of
pathway of interesting genes was determined based on
Database for Annotation Visualization and Integrated
Discovery (DAVID) http://david.abcc.ncifcrf.gov/.
The statistical significance of microarray gene expression
was assessed by computing a q-value for each gene. To
determine the q-value, we used a permutation procedure,
and for each permutation a two-sample t-statistic was
computed for each gene. The result was considered signif-
icant when the logarithmic gene expression ratio of four
independent hybridizations was more than twofold the
difference in the expression level. The accuracy of micro-
array analysis in this study was confirmed by real-time
PCR as previously done [28].
Real-time PCR analysis
The results of cDNA microarray analyses were confirmed
and validated via real-time PCR. The primers sequences
used in real-time PCR analysis are described in Table 1.
Samples were analyzed in a 20 μl reaction volume con-
taining 10 μl of SYBR premix Ex Taq (TaKaRa Bio., Inc.)Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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using a 7300 Real-Time PCR system (Applied Biosystems,
Foster, CA, USA), following the manufacturer's recom-
mendations. The relative expression level of each gene was
normalized to that of HPRT (i.e., an internal control gene)
and quantified using RQ software (Applied Biosystems).
Histopathological examination of testis
Testis tissues were fixed in Bouin's solution and immersed
in neutral formalin solution. The fixed tissues were
embedded in paraffin, sectioned at 5 μm and mounted on
slides. These sections were stained with hematoxylin and
eosin (H&E), and histopathological changes were exam-
ined under a light microscope.
Statistical analyses
Results are presented as means ± standard deviations
(SD). Absolute body weights, sexual organ weights and
AGD measurements were analyzed at the time of
necropsy. When significant changes were detected,
Tukey's multiple regression test was used to compare the
treatments (i.e., by comparing the control and experimen-
tal groups). Data were considered statistically significant
at p < 0.05.
Results
Effects of DEHP and Flu on body weight, reproductive 
organ weight and anogenital distances
Exposure of immature male rats to DEHP or Flu did not
cause any significant changes in body weight (Figure 1A).
However, a high doses of DEHP (i.e., 500 mg/kg BW/day)
or Flu (i.e., 50 mg/kg BW/day) significantly decreased the
weights of reproductive organs (e.g. testis, prostate and
seminal vehicle weights) as shown in Figure 1. Interest-
ingly, the diminution of epididymis weight was detected
in a smaller dose of DEHP and all doses of Flu treatment
group. As expected, the high doses of DEHP and Flu sig-
nificantly decreased AGD when compared with a vehicle,
demonstrating the potential effects of DEHP or Flu on
androgen-responsive organs (Figure 1F). However, any
significant effect in the androgen- dependent organs in
animals treated with TP was not observed even though
there is a tendency of gene alterations by TP as seen Figure
1. These results suggest that androgens have been linked
with alterations in several end points measured in the
immature male onset assay, but seem likely that higher
doses of TP may cause this.
Effects of DEHP and Flu on serum concentrations of 
testosterone and LH
To further explore the effects of DEHP and Flu on critical
stages in the development of the male reproductive sys-
tem, serum concentrations of testosterone and LH were
measured using an ELISA kit. As shown in Figure 2, a sig-
nificant decrease in the levels of testosterone was observed
when rats were exposed to all doses of DEHP (i.e., 10,
100, 500 mg/kg BW/day). However, no significant altera-
tion by any of the two treatments was observed in the
serum levels of LH, although these compounds showed a
tendency to decrease LH levels. TP treatment as an andro-
gen agonist increased the circulating testosterone without
affecting the levels of LH. These data suggest that DEHP
exerts an effect on the circulating levels of testosterone in
immature male rats.
Effects of DEHP and Flu on histopathology of the testes
Histopathological abnormalities in the testes of immature
male rats exposed to DEHP and Flu were examined by
hematoxylin and eosin (H&E) staining, as described in
the Materials and Methods. Testes are androgen-responsive
tissues; thus, alterations in the morphology and histology
of testes can result from the anti-androgenic effects of
chemicals. As seen in Figure 3 and 4, testes morphology
Table 1: Primer sequences for Real-time PCR analyses of gene expression
Transcript ID Gene Symbol Sequense (5'-3') Size
NM_031558 StAR Forward tcaaggaatcaaggtcctg 208
Reverse tgttcagctctgatgacacc
NM_017286 Cyp11a1 Forward Atccagcttctttcccaatc 229
Reverse caggatgaggttgaacttgg
NM_017265 HSD3b Forward Cgctgctgtcattgatgtct 299
Reverse tatgcagtgtgccaccattt
NM_133529 Cabp1 Forward tgactttgtggaactgatgg 232
Reverse gaagtccactcgtccatctc
XM_216030 Vav2 Forward cagaggagacggctgaaaac 338
Reverse gatgaggtcctccaggttga
NM_145880 Lhx1 Forward Ttctggaccgtttcctcttg 198
Reverse gaaccagatcgcttggagag
NM_001014242 Isocl Forward acacgtctgtatccagcaga 227
Reverse Tggccttaattaggttctgg
NM_017035 Plcd1 Forward agctgccaaaggtcaataag 238
Reverse ctctggccaataaagtcgttReproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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and histology were influenced by treatment with DEHP
and Flu, respectively. Degeneration of Leydig cells and dis-
orders of germ cells in the reproductive tract were noted in
response to all doses of DEHP and Flu. In addition, dila-
tation of the tubular lumen and stratification of germ cells
were observed when rats were treated with DEHP (i.e.,
100 and 500 mg/kg BW/day) (Figure 3 and 4). Hyperpla-
sia of Leydig and Sertoli cells appeared in rat testes at PND
Effects of TP, DEHP and Flu on body weight, reproductive organ weight, and anogenital distance in immature male rats (n = 4/ group) Figure 1
Effects of TP, DEHP and Flu on body weight, reproductive organ weight, and anogenital distance in immature 
male rats (n = 4/group). The weights of testes, epididymis, prostate and seminal vesicles were recorded. Data were ana-
lyzed by ANOVA, followed by Tukey's multiple regression. a: p < 0.05; b: p < 0.01 and c: p < 0.001, compared with a control.Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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36 in response to high doses of Flu (i.e., 50 mg/kg BW/
day) (Figure 4). In addition, widespread germ cells disor-
der or leydig cells degeneration resulted from treatment
with all dose of DEHP and Flu (Figure 3 and 4). These
results demonstrate the adverse effects of anti-androgenic
EDs on the male reproductive tract, particularly with
regards to spermatogenesis.
Effects of DEHP and Flu on gene expression in the testes
Gene expression in immature rat testes in response to TP,
DEHP or Flu was assessed using cDNA microarrays. In
total, 37,317 of 41,016 genes were dysregulated following
treatment with DEHP (i.e., 100 mg) or Flu (i.e., 10 mg),
when compared with a control. Among these genes, 1,272
genes were up-regulated over 2-fold change and 1,969
genes were downregulated by more than two-fold. Spe-
cific genes were then selected as marker genes for andro-
genic or anti-androgenic activities of TP, DEHP, or Flu
(Table 2 and 3), respectively, including Orc4l, Mgat4a, and
predicted  Scrt1,  Tmem93,  RGD1308066,  Omp,
RGD1561053, Cnot3, Ubxd6, RGD1561121, Olr297 and
Cilp genes. Altered genes have been also classified on the
basis of gene ontology (e.g., steroid hormone biosynthetic
process, regulation of transcription, signal transduction,
metabolic process, catabolic process, biosynthetic process,
and integral to membrane, mitochondrion and others) as
shown in Table 4. However, the biological interactions of
these proteins in response to EDs (i.e., particularly DEHP
and Flu) remains unknown. Six genes (i.e., CaBP1, Vav2,
Plcd1, Lhx1, Hsd3b and Isoc1) were randomly selected to
validate the cDNA microarray results via real-time PCR
(Figure 5). The results of these analyses suggest that these
genes may be useful markers to screen for anti-androgenic
effects of EDs in androgen-responsive tissues. In addition,
two well-known marker genes (i.e., StAR and Cyp11a1)
were used to screen for the anti-androgenic effects of these
EDs. As expected, the expressions of steroidogenesis-
related genes (i.e., StAR and Cyp11a1) were significantly
affected by Flu exposure (i.e., 50 mg/kg BW/day) (Figures
5A and 5B). To confirm the correlation between microar-
ray data and real-time PCR, we plotted the fold changes
(versus vehicle) of microarray and real-time PCR results.
There was a good correlation between the results obtained
from microarray and real-time PCR (R2 = 0.824722106, p
< 0.0001). Taken together, these results suggest that expo-
sure to DEHP and Flu resulted in an alteration of gene
expression in the testis of immature male rats. The distinct
transcriptional response to DEHP and Flu reflect that
these EDs may exert their anti-androgenic effects via dif-
ferent mechanisms.
Discussion
There are a number of mechanisms by which EDs may
alter the action of the endocrine system and interfere with
the reproduction of humans and animals. Previous stud-
ies have shown that EDs mimic the actions of natural hor-
mones and can stimulate or inhibit various enzymes
required for hormone synthesis. Consequently, EDs inter-
fere with the regulation of gene expression, disrupting the
natural hormone balance and interfering with the normal
action of the reproductive system. In particular, EDs may
exert distinct androgenic and anti-androgenic effects on
the developing male reproductive system in utero [29].
Although previous studies have examined the effects of
these chemicals on critical stages in the development of
the male reproductive system, the relationship between
molecular events and detrimental effects of these EDs is
not well described. To further explore these effects, we
used an immature rat model of development to examine
the adverse effects of DEHP and Flu on the male reproduc-
tive system. Oral treatments with DEHP (i.e., 10, 100 and
500 mg/kg BW/day) and Flu (i.e., 1, 10 and 50 mg/kg BW/
day) failed to induce significant effects on body weight in
Effects of TP, DEHP and Flu on circulating testosterone and  LH levels in immature male rats Figure 2
Effects of TP, DEHP and Flu on circulating testoster-
one and LH levels in immature male rats. A. Serum 
testosterone concentration. B. Serum LH concentrations 
were altered by ED exposure (i.e., n = 4). Data are shown as 
mean ± SEM. Significant differences were noted relative to a 
control (i.e., a, p < 0.05) or TP (i.e., b, p < 0.05).Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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a dose-dependent manner. However, high doses of DEHP
and Flu significantly decreased the weights of reproduc-
tive organs, with the exception of the epididymis.
Although treatment with high doses of DEHP failed to
induce anti-androgenic effects on epididymis weight,
these effects were observed after treatment with low doses
of DEHP (i.e., 10 mg/kg BW/day). These results provide
evidence of the anti-androgenic effects of DEHP in the
epididymis. A previous study reported that treatment with
DEHP (i.e., 500 mg/kg BW/day) failed to induce signifi-
cant effects on body weight [30]. However, other studies
have shown significant decreases in body weight in
response to Flu (i.e., 100 or 150 mg/kg BW/day) [31], sug-
gesting that these EDs differ markedly with regards to their
detrimental affects on human and animals. Further stud-
ies are required to elucidate the molecular and biochemi-
cal mechanisms underlying the effects of anti-androgenic
ED exposure in humans and animals, particularly during
the critical stages of male reproductive development.
It has been suggested that alterations in endogenous
androgen levels or dysregulation of gene expression pat-
terns causes abnormalities in male reproductive tract (i.e.,
cyptochism, hypospadia, stunted testicular growth, epidi-
dymal abnormalities, and AGD [32-34]. In addition, the
anti-androgenic and androgenic effects of EDs can be
reflected by changes in the weights of the testes, prostate
and seminal vesicle. A previous study of rat offspring indi-
cated dose-dependent reductions in the ventral and dor-
solateral prostate weights in response to DEHP [35].
Another study reported malformation of the male repro-
Effects of TP, DEHP (10, 100 mg/kg BW/day) on histopatho- logical changes in immature male rats exposed to EDs from  PND 21 to PND 35 Figure 3
Effects of TP, DEHP (10, 100 mg/kg BW/day) on his-
topathological changes in immature male rats 
exposed to EDs from PND 21 to PND 35. Testis tissues 
were fixed in Bouin's solution and immersed in neutral for-
malin solution. The fixed tissues were embedded in paraffin, 
sectioned at 5 μm and mounted on slides. These sections 
were stained with hematoxylin and eosin (i.e., HE) and his-
topathological changes were assessed under a light micro-
scope. Dilatation of the tubular lumen (a: stained signals), 
degeneration of Leydig cells (b: stained signals), and disorder 
of germ cells (c: stained signals) were observed in the testes 
of immature male rats. Results are shown at a 100 × magnifi-
cation (i.e., bar = 200 μm), a 200 × magnification (i.e., bar = 
100 μm) and a 400 × magnification (i.e., bar = 50 μm).
Effects of DEHP (500 mg/kg BW/day) and Flu on histopatho- logical changes in immature male rats exposed to EDs from  PND 21 to PND 35 Figure 4
Effects of DEHP (500 mg/kg BW/day) and Flu on his-
topathological changes in immature male rats 
exposed to EDs from PND 21 to PND 35. Testis tissues 
were fixed in Bouin's solution and immersed in neutral for-
malin solution. The fixed tissues were embedded in paraffin, 
sectioned at 5 μm and mounted on slides. These sections 
were stained with hematoxylin and eosin (i.e., HE) and his-
topathological changes were assessed under a light micro-
scope. Hyperplasia of Leydig cells, germ cell (a: stained 
signals), stratification of germ cells (b: stained signals), dilata-
tion of the tubular lumen and stratification (c: stained sig-
nals), degeneration of Leydig cells (d: stained signals), and 
disorder of germ cells (e: stained signals) were observed in 
the testes of immature male rats. Results are shown at a 100 
× magnification (i.e., bar = 200 μm), a 200 × magnification 
(i.e., bar = 100 μm) and a 400 × magnification (i.e., bar = 50 
μm).Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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ductive tract following exposure to DEHP, manifesting as
disgenesis of the epididymis, decreased sperm produc-
tion, Leydig cell hyperplasia and adenomas [36]. A signif-
icant decrease in the weights of rat testes in response to
DEHP (i.e., 250, 500, 1000 or 2000 mg/kg BW/day by
gavage) has also been reported [37]. Another study dem-
onstrated that the epididymal, prostate and seminal vesi-
cle weights of immature male rats were strongly affected
by the anti-androgenic effects of Flu at PND 20 [38]. Pre-
vious studies have proposed an androgen-dependent
marker for the anti-androgenic and androgenic effects of
EDs using AGD. A significant reduction in AGD is evoked
Table 2: Up-regulated gene induced by TP, DEHP and Flu in the immature rat testes. 
Transcript ID Gene Symbol Gene Name Fold change (compared with VE)
vs TP vs DEHP 100 vs Flu 10
TP UP
XM_345848 Scrt1_predicted scratch homolog 1, zinc finger protein (Drosophila) 5.88 1.84 1.46
XM_213394 Tmem93_predicted transmembrane protein 93 (predicted) 5.07 1.49 1.43
XM_215951 Kcng1 potassium voltage-gated channel, subfamily G, member 1 3.07 1.13 0.96
NM_001008295 Fip1l1 FIP1 like 1 (S. cerevisiae) 2.44 1.00 1.08
NM_021669 Ghrl ghrelin precursor 2.37 1.02 1.00
XM_221387 Etv5_predicted ets variant gene 5 (ets-related molecule) (predicted) 2.14 1.01 1.13
XM_215635 Apoa1bp_predicted apolipoprotein A-I binding protein (predicted) 2.11 1.31 1.22
NM_031802 Gabbr2 gamma-aminobutyric acid (GABA) B receptor 2 2.06 1.29 0.80
NM_133529 Cabp1* calcium binding protein 1 2.05 1.11 0.97
XM_216030 Vav2* Vav2 oncogene (predicted) 1.77 1.41 1.11
DEHP UP
XM_213289 RGD1308066_predicted similar to KIAA1960 protein (predicted) 0.99 3.29 1.64
NM_012616 Omp olfactory marker protein 1.07 3.08 1.19
NM_021590 Aipl1 aryl hydrocarbon receptor-interacting protein-like 1 1.31 2.91 1.22
NM_031770 Gnb5 guanine nucleotide binding protein, beta 5 1.14 2.65 1.10
NM_001000980 Olr1366 olfactory receptor 1366 1.33 2.62 1.16
NM_022625 Tpc1808 tropic 1808 1.11 2.43 1.36
NM_001014015 Rbm34 RNA binding motif protein 34 1.28 2.43 1.22
NM_199291 Doxl2 diamine oxidase-like protein 2 1.27 2.42 1.01
XM_220283 Sox8_predicted SRY-box containing gene 8 (predicted) 1.10 2.33 1.18
NM_023992 Kiss1r KISS1 receptor 1.12 2.31 1.24
NM_001000365 Olr748_predicted olfactory receptor 748 (predicted) 1.21 2.30 1.26
NM_017035 Plcd1* phospholipase C, delta 1 1.20 2.20 1.24
XM_221627 Brwd1_predicted bromodomain and WD repeat domain containing 1 
(predicted)
1.30 2.19 1.18
XM_221521 Hoxd4_predicted homeo box D4 (predicted) 0.67 2.17 0.93
XM_344627 Calm4_predicted calmodulin 4 (predicted) 1.08 2.16 0.84
XM_216225 Ppp4r2_predicted protein phosphatase 4, regulatory subunit 2 (predicted) 1.22 2.15 1.45
NM_175587 Taar7h trace-amine-associated receptor 7 h 1.14 2.14 1.11
NM_020106 Olr414_predicted olfactory receptor 414 (predicted) 1.35 2.13 0.94
NM_145880 Lhx1* LIM homeobox protein 1 1.04 1.72 1.20
Flu UP
XM_575355 RGD1561053_predicted similar to Claudin 12 (predicted) 1.49 1.16 3.18
XM_218187 Cnot3_predicted CCR4-NOT transcription complex, subunit 3 (predicted) 1.21 1.10 2.48
NM_012992 Npm1 nucleophosmin 1 1.31 1.13 2.25
NM_017265 Hsd3b1* hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid 
delta-isomerase 1
0.87 0.97 2.18
XM_214673 Cog8_predicted component of oligomeric golgi complex 8 (predicted) 0.75 0.79 2.07
XM_225336 Lrrc16_predicted leucine rich repeat containing 16 (predicted) 1.00 1.31 2.06
XM_226843 Rnasen ribonuclease III, nuclear 0.93 0.69 2.05
XM_234056 RGD1564242_predicted similar to KIAA1218 protein (predicted) 0.97 1.02 2.05
NM_013175 Sgne1 secretory granule neuroendocrine protein 1 0.83 0.81 2.04
XM_221047 Polg2_predicted polymerase (DNA directed), gamma 2, accessory subunit 
(predicted)
1.14 1.05 2.01
The cDNA microarray analysis for detection of fold changes of gene expression in the testis of immature rats following treatments with TP, DEHP 
or Flu.
Altered gene up-regulation expression was estimated by the ratio of TP, DEHP 100 mg/kg BW/day and Flu 10 mg/kg BW/day treated vs. control as 
follows.
*, These altered genes were selected for verification by real- time PCR.Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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Altered gene expressions in steroidogenesis-related genes (i.e., StAR, Cyp11a1, HSD3b1), and a common gene set containing  known TP, DEHP or Flu markers (i.e., CaBP1, Vav2, Plcd1, Lhx1, Isoc1) Figure 5
Altered gene expressions in steroidogenesis-related genes (i.e., StAR, Cyp11a1, HSD3b1), and a common gene 
set containing known TP, DEHP or Flu markers (i.e., CaBP1, Vav2, Plcd1, Lhx1, Isoc1). Altered gene expressions 
were expressed relative to controls by real-time PCR as described in the Materials and Methods. Data are presented as means 
and SEMs (i.e., n = 4 for each group). Asterisks denote significant differences, relative to a control (i.e., p < 0.05).Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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by DEHP exposure during lactation [39] and by prenatal
exposure to Flu [40]. Moreover, changes in AGD during
early postnatal periods correlate with alterations in andro-
gen-dependent development in adults [41]. In the present
study, AGD values decreased significantly in response to
high doses of DEHP or Flu; however, no alterations were
observed after treatment with their medium and low
doses. Although there is a correlation between EDs and
reproductive, developmental and behavioral changes at
high doses in experimental animals, further studies are
required to determine if low doses may also contribute to
reproductive disorders in humans and wildlife [39].
A recent study has indicated the property of phthalates
associated with endocrine disruption and these com-
pounds are believed to act as endocrine disruptors [42].
Exposure to phthalates reduces testosterone synthesis dur-
ing this critical stage of development [7]. Phthalates exert
their effects on steroidogenesis in Leydig cells via modula-
tion of testosterone-biosynthetic enzyme activity and
serum LH levels [43]. In contrast, different responses to
Flu may result from local concentrations of androgenic
and anti-androgenic compounds. Exposure to Flu may
block the physiological action of testosterone at AR sites
[44] and induce changes in circulating LH levels, due to
disturbances in the negative feedback loop between the
pituitary and the testis [40]. Although DEHP and Flu share
an anti-androgenic activity, the mechanisms by which
these EDs exert their effects on human body are distinct.
It has indicated in many previous reports that AR plays an
important role in Flu-mediated response, while phtha-
lates, including DEHP, do not interact with AR at the
physiological concentration [45]. Additionally, DEHP is
thought to activate PPAR, leading a down-regulation of
Table 3: Down-regulated gene induced by TP, DEHP and Flu in the immature rat testes.
Transcript ID Gene Symbol Gene Name Fold change (compared with VE)
vs TP vs DEHP 100 vs Flu 10
TP DOWN
NM_001012225 Mgat4a Mannoside acetylglucosaminyltransferase
4, isoenzyme A
0.30 0.69 0.74
XM_214360 Ubxd6_predicted UBX domain containing 6 (predicted) 0.35 0.82 0.63
XM_342534 Nat5_predicted N-acetyltransferase 5 (ARD1 homolog, S. cerevisiae) 
(predicted)
0.39 0.77 1.03
NM_053356 Col1a2 procollagen, type I, alpha 2 0.42 0.81 0.79
XM_345107 RGD1559810_predicted similar to hypothetical protein (predicted) 0.42 0.83 0.77
NM_133317 Tob1 transducer of ErbB-2.1 0.43 0.82 1.04
XM_341903 Nrip3_predicted nuclear receptor interacting protein 3 (predicted) 0.44 1.90 1.87
XM_229139 RGD1566225_predicted similar to RIKEN cDNA 1700001F22 (predicted) 0.44 1.00 0.82
NM_001013185 Cabc1 chaperone, ABC1 activity of bc1 complex like (S. pombe) 0.45 1.08 0.73
XM_235640 Tmem16f_predicted transmembrane protein 16F (predicted) 0.46 0.87 0.68
NM_001010966 Pigv phosphatidylinositol glycan, class V 0.49 2.21 1.73
NM_133318 Khdrbs2 KH domain containing, RNA binding, signal transduction 
associated 2
0.49 0.82 0.85
DEHP DOWN
XM_218447 RGD1561121_predicted similar to pleckstrin homology-like domain, family B, member 
3 (predicted)
1.26 0.12 0.99
NM_199092 Orc4l origin recognition complex, subunit 4-like (S. cerevisiae) 0.70 0.40 0.72
NM_031753 Alcam activated leukocyte cell adhesion molecule 0.75 0.46 0.80
NM_001014242 Isoc1* isochorismatase domain containing 1 0.85 0.46 0.90
XM_215497 Rad1_predicted RAD1 homolog (S. pombe) (predicted) 0.97 0.46 0.86
XM_575065 RGD1559623_predicted similar to RIKEN cDNA 5230400J09 (predicted) 0.93 0.48 0.69
NM_139189 Lmbrd1 LMBR1 domain containing 1 0.76 0.48 0.74
XM_236578 RGD1562949_predicted similar to mKIAA0259 protein (predicted) 0.91 0.49 1.26
XM_215487 Mrps30_predicted mitochondrial ribosomal protein S30 (predicted) 0.90 0.49 0.76
Flu DOWN
NM_001000234 Olr297_predicted olfactory receptor 297 (predicted) 1.02 1.54 0.25
XM_236348 Cilp_predicted cartilage intermediate layer protein, nucleotide 
pyrophosphohydrolase (predicted)
0.65 0.89 0.40
XM_228462 RGD1565441_predicted similar to KIAA1687 protein (predicted) 0.90 1.02 0.43
XM_219296 Rbbp6 retinoblastoma binding protein 6 0.65 0.82 0.45
NM_021653 Dio1 deiodinase, iodothyronine, type I 0.97 0.97 0.46
Altered gene down-regulation expression was estimated by the ratio of TP, DEHP 100 mg/kg BW/day and Flu 10 mg/kg BW/day treated vs. control 
as follows.
*, These altered genes were selected for verification by real- time PCR.Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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Table 4: Functional Categorization of Genes Significantly Altered via microarray analysis in immature male testes following TP, DEHP 
and Flu exposure
Functional category Transcript ID Gene Symbol
Steroid hormone biosynthetic process NM_031558 Star
NM_017286 Cyp11a1
Regulation of Transcription XM_221387 Etv5_predicted
XM_220283 Sox8_predicted
XM_221521 Hoxd4_predicted
NM_145880 Lhx1
XM_218187 Cnot3_predicted
XM_229139 RGD1566225_predicted
XM_221627 Brwd1_predicted
NM_133317 Tob1
Signal Transduction NM_031802 Gabbr2
XM_216030 Vav2_predicted
NM_012616 Omp
NM_031770 Gnb5
NM_001000980 Olr1366
NM_023992 Kiss1r
NM_175587 Taar7h
NM_020106 Olr414_predicted
NM_012992 Npm1
NM_031753 Alcam
XM_344627 Calm4_predicted
Metabolic process NM_021590 Aipl1
NM_001012225 Mgat4a
XM_342534 Nat5_predicted
NM_001014242 Isoc1
XM_236348 Cilp_predicted
Catabolic process NM_022625 Tpc1808
NM_017035 Plcd1
Biosynthetic process NM_017265 Hsd3b1
NM_001010966 Pigv
NM_021653 Dio1
Integral to membrane XM_213394 Tmem93_predicted
NM_001000365 Olr748_predicted
XM_575355 RGD1561053_predicted
XM_214673 Cog8_predicted
XM_214360 Ubxd6_predicted
NM_001000234 Olr297_predicted
NM_139189 Lmbrd1
XM_235640 Tmem16f_predicted
Mitochondrion NM_001013185 Cabc1
XM_215487 Mrps30_predicted
Protein binding XM_215635 Apoa1bp_predicted
NM_133529 Cabp1
NM_013175 Sgne1
XM_221047 Polg2_predicted
NM_053356 Col1a2
NM_133318 Khdrbs2
XM_228462 RGD1565441_predicted
XM_219296 Rbbp6Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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SR-B1 and PBR or effects on SF-1 to consequently regulate
steroidogenesis-related genes [16]. To further understand
the effects of DEHP and Flu during the critical stages of
male reproductive development, we measured the serum
concentrations of testosterone and LH. However, expo-
sure to all doses of Flu and DEHP failed to induce a signif-
icant effect in the serum LH levels, while a significant
decreased level in the serum concentrations of testoster-
one was observed in response to all doses of DEHP. We
did not expect to observe Flu-induced effect on serum
concentrations of testosterone and LH, however, the
response of Flu on their serum concentrations may be
explained by the lack of a negative feedback mechanism.
Further experiments with larger sample sizes are required
to verify these findings. It has been indicated that expo-
sure to a high dose of DEHP caused a decrease in testoster-
one production and consequently reduced AGD value
[46]. In this study, serum testosterone concentration and
AGD value were reduced in response to a high dose of
DEHP, suggesting that an alteration in testosterone syn-
thesis may result from phthalate-induced dysfunctional
interaction between Leydig and Sertoli cells [47]. Thus,
the pathological changes induced by anti-androgenic
effects in the testis during male reproductive tract develop-
ment may alter serum testosterone levels.
Testes are androgen-responsive tissues, and alterations in
the morphology and histology of testes can reflect the
anti-androgenicity effects of chemicals. In addition, an
evaluation of histological and biological effects is very
important to understand the potential risk impacts for
spermatogenesis from endocrine disrupting chemicals
[48]. In this study, histopathological changes in the testes
of immature male rats exposed to DEHP and Flu were
examined, and abnormalities in the cell morphology and
histology of the testes were observed (i.e., abnormal testic-
ular development or dysgenesis, Leydig cell hyperplasia,
morphologically distorted tubules, differentiated Sertoli
cells and abnormal germ cells), particularly in response to
high doses of DEHP and Flu. A previous study indicated
that in utero exposure to DEHP (1,000 mg/kg BW) caused
the dilatation and atrophy of seminiferous tubules in rats.
In addition, exposure to DEHP (500 mg/kg BW) may
result in the abnormalities of the cell morphology in
which multinucleated germ cells were observed in sem-
iniferous cords [49]. Another study has indicated the age-
related difference in the toxic effect(s) of this ED in the tes-
tis of rats [50]. A testicular atrophy and/or a decline in zinc
concentration were observed when exposure of immature
rats to DEHP [51], demonstrating the DEHP- and Flu-
induced effects on male reproductive development, par-
ticularly with regards to spermatogenesis.
A previous study has investigated the alteration in the
gene expression following DEHP treatment in which
exposure to this compound caused a dysregulation in the
expression of many genes, including apoptosis-, cell pro-
liferation-, metabolism-, cell adhesion- and immune
response- related genes [52]. In this study, the gene
expression in immature rat testes was also assessed via
cDNA microarray assays. A total of 37,317 genes were dys-
regulated in response to DEHP (i.e., 100 mg) and Flu (i.e.,
10 mg) treatment, when compared with a control. Among
these genes, 1,272 were overexpressed by more than two
fold, and 1,969 genes were downregulated (Table 2 and
3). Some of these genes were chosen for use as marker
genes. We previously demonstrated that maternal expo-
sure to DEHP and Flu modulates the expression of fetal
StAR, Cyp11a1 and Hsd3b1 genes, wherein DEHP treat-
ment downregulated transcription [53]. However, no sig-
nificant effects were observed in the current study.
Interestingly, treatment with high doses of Flu signifi-
cantly increased the expression of these genes (i.e., by 4-
to 6-fold). Several genes shown in Table 2 and 3 [i.e., cal-
Others XM_215951 Kcng1
NM_001008295 Fip1l1
NM_021669 Ghrl
XM_213289 RGD1308066_predicted
NM_022625 Tpc1808
NM_001014015 Rbm34
NM_199291 Doxl2
XM_216225 Ppp4r2_predicted
XM_225336 Lrrc16_predicted
XM_226843 Rnasen
XM_234056 RGD1564242_predicted
XM_345107 RGD1559810_predicted
XM_341903 Nrip3_predicted
XM_218447 RGD1561121_predicted
NM_199092 Orc4l
XM_215497 Rad1_predicted
XM_575065 RGD1559623_predicted
Table 4: Functional Categorization of Genes Significantly Altered via microarray analysis in immature male testes following TP, DEHP 
and Flu exposure (Continued)Reproductive Biology and Endocrinology 2009, 7:104 http://www.rbej.com/content/7/1/104
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cium binding protein 1(CaBP1); vav2 oncogene- pre-
dicted (Vav2- predicted); phospholipase C delta 1 (Plcd1);
lim homeobox protein 1 (Lhx1) and isochorismatase
domain containing 1 (Isoc1)] were previously identified
because of their direct or indirect involvement in physio-
logical processes (e.g., lipid or steroid metabolism, sex
determination, calcium transduction or cell prolifera-
tion). However, the biological interactions of these pro-
teins in response to EDs (i.e., particularly DEHP and Flu)
remains unknown. In current study, we also found that
some genes were strongly up-regulated by TP treatment,
whereas no differences at transcriptional levels were
observed in the testes of rats exposed to DEHP and/or Flu.
Furthermore, expression of other genes, including nuclear
receptor interacting protein 3 (predicted) and phosphati-
dylinositol glycan, class V, were decreased markedly in TP
treated group, while an enhancement in expression of
these genes was observed following DEHP or Flu treat-
ment. A distinct response to TP and DEHP/Flu may reflect
hormone properties of tested chemicals. Additionally, a
different pattern of gene expression also was found
between DEHP and Flu treatment. These distinct
responses to DEHP and Flu may be explained by the dif-
ferential mechanism of actions of the two anti-androgenic
EDs. The discrepancy was observed in the microarray
results compared to the previous ones, which appears to
be derived from different microarray system employed
and different experimental environments among the stud-
ies.
It has been reported that calcium binding protein-1 (i.e.,
encoded by CaBP1) functions as a calmodulin-like pro-
tein that modulates Ca2+ channel activities [54]. An inter-
action between Ca2+ channels and CaBP1 may regulate
the Ca2+-dependent forms of synaptic plasticity by inhib-
iting Ca2+ influx into neurons [55]. In this study, the
expression of CaBP1 was significantly up-regulated by TP
exposure. Our data revealed that exposure to TP activated
the predicted Vav2 oncogene. The Vav2 gene is involved in
many biological processes, including the B- and T-cell
receptor signaling pathways, leukocyte transendothelial
migration, natural killer cell-mediated cytotoxicity and
regulation of the actin cytoskeleton. Some previous stud-
ies have demonstrated an appearance of CaBP1 and Vav2
oncogene genes during spermatogenesis, suggesting their
potential roles in the critical window stage of male repro-
ductive system development [56,57]. Phospholipase C
delta 1 (Plcd1), a ubiquitous enzyme, helps regulate a vari-
ety of cellular processes. The Plcd1 gene has been detected
in the plasma membrane, the cytoplasm [58], and liver
mitochondria [59], and the involvement of Plcd in cardiac
function has also been reported [60]. In addition, the
activity of Plcd1 is affected by cytoplasmic concentrations
of Ca2+ [61]. A previous study also demonstrated that
FSH-induced Ca(2+) influx is mediated by the Plcd1 sign-
aling pathway in rat Sertoli cells [62]. Moreover, a testo-
sterone-induced increase in intracellular Ca2+ occurs via
activation of a plasma membrane receptor associated with
the phospholipase C signaling pathway [63]. Our results
revealed a significant increase in the expression of its path-
way. In addition, we found that the expression of LIM
homeobox gene 1 (Lhx1) was significantly modulated by
DEHP, suggesting that this gene is a potential indicator for
the effects of DEHP on androgen-responsive tissues. As a
member of the large homeobox gene family, Lhx1 plays
an important role in the stabilization of the intermediate
mesoderm and in the formation of urogenital ridges [64].
This gene is expressed in the comma- and S-shaped bodies
of the metanephric mesenchyme, as well as the develop-
ing Müllerian duct [65]. In the male reproductive system,
Lhx1 plays an important role in early gonad development,
sex-reversal and gonadal cell proliferation. Several studies
have reported the involvement of Isoc1  in progressive
chronic renal failure in rats [66]. Sexual hormones (e.g.,
estradiol, testosterone, prolactin and FSH) concentrations
are commonly affected by chronic renal failure and the
dysfunction of sex steroids may contribute to the emer-
gence of renal osteodystrophy [67]. Our results showed a
6-fold downregulation in Isco1 gene expression after expo-
sure to DEHP, representing an anti-androgen-like ED
exposure. These results demonstrate the effects of EDs on
sexual hormone abnormalities, and are likely to induce
similar changes in the reproductive development of male
humans and rats. Overall, our data indicated that the
these changes may reflect an impact of chemical exposure
on transcriptional level of gene expression and associated
with histology changes of Leydig cells, Sertoli cells and/or
germ cells, however the role(s) of these altered genes to
explain a change in altered phenotype or morphology has
unknown. It is expected for us to investigate the molecular
events of these maker genes in the histopathological testis
changes when EDs exposure during the critical male
reproductive development stage in a further study.
Taken together, our findings indicate that exposure to
DEHP and Flu results in an alteration in gene expression
in the testes of immature male rats. In addition, these
chemicals exert distinct anti-androgenic effects on the
male reproductive system. Our findings provide new
insight into the molecular mechanisms underlying the
detrimental impacts of anti-androgenic-EDs in androgen-
responsive organs, in particular, in developing male
reproductive tracts.
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